Free Republic

Despite progress in combating antimicrobial resistance (AMR) in the U.S. since its peak during the COVID-19 pandemic, hospital-acquired AMR infections remain well above pre-pandemic levels, according to a major new study examining AMR before, during, and after the COVID-19 pandemic in 120 US hospitals. The study was led by Dr. Christina Yek from the US National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and is being presented at this year's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April). It reveals that AMR rates remain high largely due to the persistence...

Antimicrobial resistance stewardship programs have to be prioritized, keeping the demands of the continuing Covid-19 pandemic in context On March 11, 2020, the World Health Organization (WHO) declared COVID-19, the disease caused by the SARS-CoV-2 virus, a pandemic. Two years later, the shadow of the Covid pandemic is still looming over us. While the world is making valiant attempts to move into the post-pandemic phase, the situation is akin to “one step forward, two-step backward”, as new variants of this virus are still emerging. Covid-19 has taken center stage in every facet of life. Policymakers and medical personnel are still...